<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23304">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02803411</url>
  </required_header>
  <id_info>
    <org_study_id>4-2016-0263</org_study_id>
    <nct_id>NCT02803411</nct_id>
  </id_info>
  <brief_title>Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)</brief_title>
  <official_title>Progression of AtheRosclerotic PlAque DetermIned by Computed TomoGraphic Angiography Imaging(PARADIGM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Yonsei University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital da Luz, Portugal</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of California, Los Angeles</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Centro Cardiologico Monzino</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of British Columbia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>German Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute of Cardiology, Laranjeiras, Brazil</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Weill Medical College of Cornell University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Yonsei University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To describe the natural history of the coronary atherosclerotic plaque development and
      progression in mild to moderate CAD over time by CCTA with demographic and laboratory data
      for refinement of risk stratification of patients referred for CCTA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All PARADIGM study patients underwent initial and follow-up CCTA based on order from their
      primary physician. Demographic data, targeted medical history, cardiovascular risk factors,
      and laboratory data was prospectively collected in electronic case report forms (eCRFs) at
      the time of the initial CCTA and at the time of follow-up CCTA.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2003</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">January 2026</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Change in plaque volume and composition detected by follow up CCTA</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cardiac mortality (yes or no)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction (yes or no)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unstable angina requiring hospitalization (yes or no)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Revascularization (yes or no)</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">5000</enrollment>
  <condition>Coronary Heart Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Study population is patients with suspected but not known CAD who had undergone serial
        CCTA by physician referral. Sites that had collected cohorts of CCTA patients with
        symptoms, risk factors, CCTA image data, and outcomes were invited to contribute data for
        a merged database. This sample includes patients with suspected but without known CAD, and
        asymptomatic subjects undergoing CCTA for risk stratification to evaluate the significance
        of changes in CCTA findings in different clinical contexts.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients underwent two or more clinically indicated CCTA with 64-detector rows or
             greater for CAD evaluation

          -  patients underwent at least 2 year interval between the baseline and follow-up CCTA

          -  No medical history of CAD at baseline

        Exclusion Criteria:

          -  unavailable either clinical or laboratory data within 1 month from index CCTA or
             follow-up CCTA

          -  patients with prior revascularization before the index CCTA

          -  poor image quality of CCTA
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hyuk-Jae Chang, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yonsei Univerity</affiliation>
  </overall_official>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 13, 2016</lastchanged_date>
  <firstreceived_date>June 3, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Yonsei University</investigator_affiliation>
    <investigator_full_name>Hyuk-Jae Chang</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Coronary Heart Disease</keyword>
  <keyword>Coronary Computed Tomography Angiography (CCTA)</keyword>
  <keyword>Coronary Atherosclerotic Plaque</keyword>
  <keyword>coronary atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Plaque, Atherosclerotic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
